Russian Federation aims mass COVID-19 vaccination from October
- by Virginia Carter
- in World Media
- — Aug 2, 2020
On the global front, Dr Anthony Fauci said that 250,000 people have registered on the National Institute of Heath's website to take part in experimental vaccine trials.
Professor Dr. Robin Shattok of the Imperial College London said in an interview to The Associated Press that he and his colleagues recently concluded the gradual and hard process of subjecting the vaccine to a test, which involves the administration of low doses to preliminary participants.
Coronavirus vaccine news update: Scientists from all the countries of the world including India are engaged in developing the coronavirus vaccine.
On Friday, the leading infectious disease expert in the US, Dr Anthony Fauci, said he hoped that Russian Federation - and China - were "actually testing the vaccine" before administering them to anyone.
A study by Johnson & Johnson shows work on a vaccine, which has been tested on monkeys, creates a strong immune response that protects against infection after a single dose.
Russian Federation expects to start mass anti-coronavirus vaccinations, across the country, by October, the country's health minister has said. AstraZeneca Plc, Moderna Inc. and Pfizer Inc. have all started late-stage testing for Covid-19 vaccines, with initial results from some of the human trials expected as early as October.
The Russian vaccine based on adenovirus vectors, developed by military and government scientists, is in Phase II trials with plans to start the next and final phase after August 3.
"We are going very quickly".
The officials told the outlet that the vaccine will be approved for public use with frontline healthcare workers receiving it first. Several other vaccines by China, Britain and Russian Federation are under triaL. "Now, the package of documents for the procedure of registration [of the vaccine] is being prepared", Murashko added.
A total of 79 volunteers have so far been successfully administered the first dose of indigenous Covid-19 vaccine, Covaxin, at Pt Bhagwat Dayal Sharma Post Graduate Institute of Medical Science here under the first phase of its human clinical trial.
